Article Details

Genovis Announces Strategic Divestment of Antibody Business to Leinco Technologies Inc.

Retrieved on: 2024-08-19 18:50:52

Tags for this article:

Click the tags to see associated articles and topics

Genovis Announces Strategic Divestment of Antibody Business to Leinco Technologies Inc.. View article details on hiswai:

Excerpt

The divestment follows a strategic review by Genovis, which identified the need to concentrate on its core enzyme business—a sector where the company ...

Article found on: news.cision.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up